FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maya Buch

Research Profile

Disorders

Rheumatoid Arthritis

Chemicals & Drugs

Concepts & Ideas

Procedures

Anatomy

B-Lymphocytes

Co-author Network

Publications

TOP 3
Maya H Buch; Mahesh Parmar; Sue Pavitt; Paul Emery
Creative trial design in RA: optimizing patient outcomes.
Sudipto Das; Shouvik Dass; Meritxell Fernandez Matilla; Andrew C Rawstron; Edward M Vital; Maya H Buch; Paul Emery
Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis.
L R Coulthard; L J Dickie; Paul Emery; J Geiler; R J Mathews; Domini Bryer; Maya H Buch; L D Church; D L Cooper; Ann W Morgan; Sinisa Savic; C Wong; M F McDermott
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maya Buch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maya H Buch; Mahesh Parmar; Sue Pavitt; Paul Emery
Creative trial design in RA: optimizing patient outcomes.
Nature reviews. Rheumatology 2013;9(3):183-94.
2013: Sudipto Das; Shouvik Dass; Meritxell Fernandez Matilla; Andrew C Rawstron; Edward M Vital; Maya H Buch; Paul Emery
Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis.
Annals of the rheumatic diseases 2013;72(3):463-4.
2012: L R Coulthard; L J Dickie; Paul Emery; J Geiler; R J Mathews; Domini Bryer; Maya H Buch; L D Church; D L Cooper; Ann W Morgan; Sinisa Savic; C Wong; M F McDermott
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.
Clinical and experimental immunology 2012;170(1):36-46.
2012: Richard J Wakefield; Marina Backhaus; Peter Balint; Maya H Buch; Gerd R Burmester; Maria Antonietta D'Agostino; Eugenio de Miguel; Maxime Dougados; Cristina Estrach; Walter Grassi; Marwin Gutierrez; Annamaria Iagnocco; Kei Ikeda; Esperanza Naredo; Mikkel Ostergaard; Benazir Saleem; Lene Terslev; Robert Thompson; Paul Emery
After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?
Postgraduate medical journal 2012;88(1042):482-6.
2012: Sarah M Churchman; Paul Emery; Janina Geiler; Elizabeth A Horner; Michael F McDermott; Rekha Parmar; Maya H Buch; Leigh D Church; Frederique Ponchel
Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor.
Clinical and experimental rheumatology 2012;30(4):534-42.
2012: Richard J Wakefield; Marina Backhaus; Peter Balint; Maya H Buch; Gerd R Burmester; Maria Antonietta D'Agostino; Eugenio de Miguel; Maxime Dougados; Cristina Estrach; Walter Grassi; Marwin Gutierrez; Annamaria Iagnocco; Kei Ikeda; Esperanza Naredo; Mikkel Ostergaard; Benazir Saleem; Lene Terslev; Robert Thompson; Paul Emery
After treat-to-target: can a targeted ultrasound initiative improve RA outcomes?
Annals of the rheumatic diseases 2012;71(6):799-803.
2012: Maya H Buch; Andrea Rubbert-Roth; Gianfranco Ferraccioli
To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50.
Autoimmunity reviews 2012;11(8):558-62.
2012: Paul Emery; Maya H Buch
Towards an optimum strategy in rheumatoid arthritis.
Lancet 2012;379(9827):1682-4.
2012: Begonya Alcacer-Pitarch; Maya H Buch; Howard Collier; Christopher P Denton; Paul Emery; Janine Gray; Philip S Helliwell; Ariane Herrick; Lorraine Loughrey; Nuria Navarro-Coy; Sue Pavitt; Heidi J Siddle; Jonathan Wright; Anthony C Redmond
Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol.
BMC musculoskeletal disorders 2012;13():11.
2011: Begonya Alcacer-Pitarch; Maya H Buch; Paul Emery; Farina Hashmi; Heidi J Siddle; Anthony C Redmond
Foot health needs in people with systemic sclerosis: an audit of foot health care provision.
Clinical rheumatology 2011;30(12):1611-5.
2011: Edward M Vital; Maya H Buch; Shouvik Dass; Karen Henshaw; Michael F Martin; Colin T Pease; Frederique Ponchel; Andy C Rawstron; Paul Emery
B cell biomarkers of rituximab responses in systemic lupus erythematosus.
Arthritis and rheumatism 2011;63(10):3038-47.
2011: Maya H Buch; Daniel Aletaha; Paul Emery; Josef S Smolen
Reporting of long-term extension studies: lack of consistency calls for consensus.
Annals of the rheumatic diseases 2011;70(6):886-90.
2011: Maya H Buch; GR Burmester; Thomas Dörner; Paul Emery; Gianfranco Ferraccioli; Jacques-Eric Gottenberg; John Isaacs; Tore K Kvien; Xavier Mariette; E Martin-Mola; Karel Pavelka; Josef S Smolen; Paul P Tak; Desiree van der Heijde; Ronald F van Vollenhoven; Neil Betteridge; Ferdinand C Breedveld
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2011;70(6):909-20.
2011: Maya H Buch; Paul Emery
New therapies in the management of rheumatoid arthritis.
Current opinion in rheumatology 2011;23(3):245-51.
2011: Giuseppina Abignano; Maya H Buch; Paul Emery; francesco del galdo
Biomarkers in the management of scleroderma: an update.
Current rheumatology reports 2011;13(1):4-12.
2010: J L Nam; Kevin L Winthrop; R F van Vollenhoven; K Pavelka; G Valesini; Elizabeth M A Hensor; G Worthy; R Landewé; J S Smolen; Paul Emery; Maya H Buch
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.
Annals of the rheumatic diseases 2010;69(6):976-86.
2010: Maya H Buch
Sequential use of biologic therapy in rheumatoid arthritis.
Current opinion in rheumatology 2010;22(3):321-9.
2010: Edward M Vital; S Dass; Andy C Rawstron; Maya H Buch; vincent GOËB; Karen Henshaw; Frederique Ponchel; Paul Emery
Management of nonresponse to rituximab in rheumatoid arthritis: predictors and outcome of re-treatment.
Arthritis and rheumatism 2010;62(5):1273-9.
2010: Sarah Horton; Maya H Buch; Paul Emery
Efficacy, tolerability and safety of biologic therapy in rheumatoid disease: patient considerations.
Drug, healthcare and patient safety 2010;2():101-19.
2010: Paul Emery; Maya H Buch; Andrew Ostör; Bruce Kirkham; Peter Taylor; Cristina Estrach; Tim Jenkinson; Iain McInnes; Duncan Porter
Symmetrical polyarthritis. Time for treatment targets in rheumatoid arthritis.
BMJ (Clinical research ed.) 2010;341():c4170.
2009: Maya H Buch; D L Boyle; S Rosengren; B Saleem; Richard Reece; Laura A Rhodes; Aleksandra Radjenovic; Anne English; H Tang; G Vratsanos; Philip O'Connor; Gary S Firestein; Paul Emery
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.
Annals of the rheumatic diseases 2009;68(7):1220-7.
2009: Edward M Vital; Shouvik Dass; Maya H Buch; Andy C Rawstron; Frederique Ponchel; Dennis McGonagle; Paul Emery
Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al.
Arthritis and rheumatism 2009;60(6):1867; author reply 1867-8.
2009: vincent GOËB; Maya H Buch; Edward M Vital; Paul Emery
Costimulation blockade in rheumatic diseases: where we are?
Current opinion in rheumatology 2009;21(3):244-50.
2008: Maya H Buch; Richard Reece; Mark A Quinn; Anne English; G Cunnane; Karen Henshaw; Sarah J Bingham; Victoria Bejarano; John Isaacs; Paul Emery
The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab).
Rheumatology (Oxford, England) 2008;47(10):1469-75.
2008: Maya H Buch; Edward M Vital; Paul Emery
Abatacept in the treatment of rheumatoid arthritis.
Arthritis research & therapy 2008;10 Suppl 1():S5.
2007: Maya H Buch; Sarah J Bingham; Domini Bryer; Paul Emery
Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.
Rheumatology (Oxford, England) 2007;46(7):1153-6.
2007: Maya H Buch; Sarah J Bingham; Victoria Bejarano; Domini Bryer; Jo White; Richard Reece; Mark Quinn; Paul Emery
Therapy of patients with rheumatoid arthritis: outcome of infliximab failures switched to etanercept.
Arthritis and rheumatism 2007;57(3):448-53.
2006: Maya H Buch; Paul Emery
Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?
Nature clinical practice. Rheumatology 2006;2(6):288-9.
2006: Maya H Buch; Domini Bryer; S Lindsay; B Rees-Evans; A Fairclough; Paul Emery
Shortening infusion times for infliximab administration.
Rheumatology (Oxford, England) 2006;45(4):485-6.
2005: Frederique Ponchel; Robert J Verburg; Sarah J Bingham; Andrew K Brown; John Moore; Andrew Protheroe; Kath Short; Catherine A Lawson; Ann W Morgan; Mark Quinn; Maya H Buch; Sarah L Field; Sarah L Maltby; Aurelie Masurel; Susan H Douglas; Liz Straszynski; Ursula Fearon; douglas veale; Poulam Patel; Dennis McGonagle; John Snowden; Alexander F Markham; David Ma; Jacob M van Laar; Helen A Papadaki; Paul Emery; John D Isaacs
Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia.
Arthritis research & therapy 2005;7(1):R80-92.
2005: Maya H Buch; Yohei Seto; Sarah J Bingham; Victoria Bejarano; Domini Bryer; Jo White; Paul Emery
C-reactive protein as a predictor of infliximab treatment outcome in patients with rheumatoid arthritis: defining subtypes of nonresponse and subsequent response to etanercept.
Arthritis and rheumatism 2005;52(1):42-8.
2004: Sarah J Bingham; Maya H Buch; Michael Kerr; Paul Emery; Anabela Tavares Valadäo Barcelos
Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
Arthritis and rheumatism 2004;50(12):4072-3.
2004: Maya H Buch; Philip Conaghan; Mark A Quinn; Sarah J Bingham; douglas veale; Paul Emery
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
Annals of the rheumatic diseases 2004;63(10):1344-6.
2004: Maya H Buch; Sarah J Bingham; Yohei Seto; Dennis McGonagle; Victoria Bejarano; Jo White; Paul Emery
Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade.
Arthritis and rheumatism 2004;50(3):725-8.
2004: Sarah J Bingham; Maya H Buch; Alan Tennant; Paul Emery
The impact of escalating conventional therapy in rheumatoid arthritis patients referred for anti-tumour necrosis factor-alpha therapy.
Rheumatology (Oxford, England) 2004;43(3):364-8.
2004: Maya H Buch; H Marzo-Ortega; Sarah J Bingham; Paul Emery
Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
Rheumatology (Oxford, England) 2004;43(2):243-4.
2003: Stephen J Jarrett; Gaye Cunnane; Philip Conaghan; Sarah J Bingham; Maya H Buch; Mark A Quinn; Paul Emery
Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series.
The Journal of rheumatology 2003;30(10):2287-91.
2003: Sarah J Bingham; Maya H Buch; S Lindsay; A Pollard; J White; Paul Emery
Parenteral methotrexate should be given before biological therapy.
Rheumatology (Oxford, England) 2003;42(8):1009-10.
2003: Ann W Morgan; V H Keyte; S J Babbage; James Robinson; Frederique Ponchel; Jennifer H Barrett; Bipinchandra Bhakta; Sarah J Bingham; Maya H Buch; Philip Conaghan; A K S Gough; M Green; Catherine A Lawson; Colin Pease; Alexander F Markham; W E R Ollier; Paul Emery; J Worthington; John D Isaacs
FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study.
Rheumatology (Oxford, England) 2003;42(4):528-33.
2002: Frederique Ponchel; Ann W Morgan; Sarah J Bingham; Mark Quinn; Maya H Buch; Robert J Verburg; Judy Henwood; Susan H Douglas; Aurelie Masurel; Philip Conaghan; Moji Gesinde; Julia Taylor; Alexander F Markham; Paul Emery; Jacob M van Laar; John D Isaacs
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.
Blood 2002;100(13):4550-6.